These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8577372)

  • 41. Dual modulation of dopamine release from anterior nucleus accumbens through cholecystokinin-B receptor subsites.
    Léna I; Roques BP; Durieux C
    J Neurochem; 1997 Jan; 68(1):162-8. PubMed ID: 8978722
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selectivity of cholecystokinin (CCK) receptor antagonists, MK-329 and L-365,260, for axonally-transported CCK binding sites on the rat vagus nerve.
    Mercer JG; Lawrence CB
    Neurosci Lett; 1992 Mar; 137(2):229-31. PubMed ID: 1374868
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cholecystokinin-B receptor ligands of the dipeptoid series act as agonists on rat stomach histidine decarboxylase.
    Ding XQ; Chen D; Håkanson R
    Gastroenterology; 1995 Oct; 109(4):1181-7. PubMed ID: 7557084
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression and sexual dimorphism of galanin messenger ribonucleic acid in growth hormone-releasing hormone neurons of the rat during development.
    Delemarre-van de Waal HA; Burton KA; Kabigting EB; Steiner RA; Clifton DK
    Endocrinology; 1994 Feb; 134(2):665-71. PubMed ID: 7507832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Homolateral cerebrocortical changes in neuropeptide and receptor expression after minimal cortical infarction.
    Van Bree L; Zhang F; Schiffmann SN; Halleux P; Mailleux P; Vanderhaeghen JJ
    Neuroscience; 1995 Dec; 69(3):847-58. PubMed ID: 8596653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunocytochemical detection of cholecystokinin and corticotrophin-releasing hormone neuropeptides in the hypothalamic paraventricular nucleus of the jerboa (Jaculus orientalis): modulation by immobilisation stress.
    Barakat Y; Pape JR; Boutahricht M; El Ouezzani S; Alaoui A; Chaigniau M; Tramu G; Magoul R
    J Neuroendocrinol; 2006 Oct; 18(10):767-75. PubMed ID: 16965295
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of hypothalamic cholecystokinin octapeptide in the colonic motor response to a meal in rats.
    Liberge M; Arruebo MP; Bueno L
    Gastroenterology; 1991 Feb; 100(2):441-9. PubMed ID: 1985040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats.
    Honore P; Buritova J; Fournié-Zaluski MC; Roques BP; Besson JM
    J Pharmacol Exp Ther; 1997 Apr; 281(1):208-17. PubMed ID: 9103499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peripheral cholecystokinin A and cholecystokinin B receptors mediate stimulation of gastric pepsinogen and acid secretion following intracerebroventricular injection of cholecystokinin-8-sulphate.
    Blandizzi C; Lazzeri G; Carignani D; Colucci R; Baschiera F; Tognetti M; Placanica G; Del Tacca M
    Ital J Gastroenterol Hepatol; 1999; 31(6):440-8. PubMed ID: 10575559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Failure of cholecystokinin antagonists to modify the discriminative stimulus effects of cocaine.
    Spealman RD
    Pharmacol Biochem Behav; 1992 Oct; 43(2):613-6. PubMed ID: 1438498
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Measurement of central nervous system activity of systemically administered CCKB receptor antagonists by ex vivo binding.
    Patel S; Chapman KL; Heald A; Smith AJ; Freedman SB
    Eur J Pharmacol; 1994 Mar; 253(3):237-44. PubMed ID: 8200418
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
    Zhou W; Povoski SP; Bell RH
    J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intracerebroventricular cholecystokinin A-receptor antagonist does not reduce satiation by endogenous CCK.
    Brenner LA; Ritter RC
    Physiol Behav; 1998 Feb; 63(4):711-6. PubMed ID: 9523920
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of alpha1D adrenergic receptor messenger RNA in oxytocin- and corticotropin-releasing hormone-synthesizing neurons in the rat paraventricular nucleus.
    Sands SA; Morilak DA
    Neuroscience; 1999; 91(2):639-49. PubMed ID: 10366021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduction of [125I]Bolton Hunter CCK8 and [3H]MK-329 (devazepide) binding to CCK receptors in the substantia nigra/VTA complex and its forebrain projection areas following MPTP-induced hemi-parkinsonism in the monkey.
    Graham WC; Hill DR; Woodruff GN; Sambrook MA; Crossman AR
    Neurosci Lett; 1991 Sep; 131(1):129-34. PubMed ID: 1791971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of cholecystokininA receptor agonist activity by a family of cholecystokininB receptor antagonists.
    Blevins GT; van de Westerlo EM; Yule DI; Williams JA
    J Pharmacol Exp Ther; 1994 Jun; 269(3):911-6. PubMed ID: 7516969
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological profile of TP-680, a new cholecystokininA receptor antagonist.
    Akiyama T; Tachibana I; Hirohata Y; Shirohara H; Yamamoto M; Otsuki M
    Br J Pharmacol; 1996 Apr; 117(7):1558-64. PubMed ID: 8730754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heterogeneity of CCK-B receptors involved in animal models of anxiety.
    Derrien M; McCort-Tranchepain I; Ducos B; Roques BP; Durieux C
    Pharmacol Biochem Behav; 1994 Sep; 49(1):133-41. PubMed ID: 7816864
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cholecystokinin inhibits peripheral opioid analgesia in inflamed tissue.
    Schäfer M; Zhou L; Stein C
    Neuroscience; 1998 Jan; 82(2):603-11. PubMed ID: 9466464
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patterns of expression of SSTR1 and SSTR2 somatostatin receptor subtypes in the hypothalamus of the adult rat: relationship to neuroendocrine function.
    Beaudet A; Greenspun D; Raelson J; Tannenbaum GS
    Neuroscience; 1995 Mar; 65(2):551-61. PubMed ID: 7777168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.